E Kok
Impact in
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
Papers in
- Co-authors
- Norman B. Javitt (18 shared papers)Karl E. Anderson (1 shared paper)Shlomo Burstein (5 shared papers)Skaidrite K. Krisans (1 shared paper)Marcel Gut (3 shared papers)Bertram I. Cohen (3 shared papers)Raphael Pfeffer (1 shared paper)Elliot R. Siegel (1 shared paper)
- Journals
- Journal of Biological Chemistry (5 papers)Journal of Lipid Research (4 papers)Pediatric Research (2 papers)Developmental Medicine & Child Neurology (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesJapanNetherlands
In The Last Decade
E Kok
20 papers receiving 550 citations
Peers
Comparison fields: 5 of 60
- Clinical Biochemistry 100
- Oncology 305
- Pharmacology 89
- Surgery 370
- Biochemistry 42
Countries citing papers authored by E Kok
This map shows the geographic impact of E Kok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Kok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Kok more than expected).
Fields of papers citing papers by E Kok
This network shows the impact of papers produced by E Kok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Kok. The network helps show where E Kok may publish in the future.
Co-authors
The 23 scholars most cited alongside E Kok, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1972 | 147 | |
| 2 | 1981 | 105 | |
| 3 | 1985 | 53 | |
| 4 | 1973 | 44 | |
| 5 | 1982 | 43 | |
| 6 | 1989 | 39 | |
| 7 | 1989 | 38 | |
| 8 | 1988 | 32 | |
| 9 | 1981 | 24 | |
| 10 | 1986 | 24 | |
| 11 | 1982 | 18 | |
| 12 | 1976 | 16 | |
| 13 | Severe hypertriglyceridaemia associated with the use of capecitabine. | 2012 | 9 |
| 14 | 1984 | 8 | |
| 15 | 1990 | 6 | |
| 16 | 1984 | 3 | |
| 17 | 1990 | 2 | |
| 18 | 1986 | 2 | |
| 19 | 2022 | 1 | |
| 20 | 1973 | 1 |
About E Kok
E Kok is a scholar working on Surgery, Oncology, Molecular Biology, Clinical Biochemistry and Spectroscopy, having authored 20 papers that have together received 615 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (10 papers), Cholesterol and Lipid Metabolism (8 papers), Metabolism and Genetic Disorders (6 papers), Pediatric Hepatobiliary Diseases and Treatments (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Enzyme Catalysis and Immobilization (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Lipid metabolism and biosynthesis (2 papers). The work is most often cited by research in Clinical Biochemistry (100 citations), Oncology (305 citations), Pharmacology (89 citations), Surgery (370 citations) and Biochemistry (42 citations). E Kok has collaborated with scholars based in United States, Japan and Netherlands. Frequent co-authors include Norman B. Javitt, Karl E. Anderson, Shlomo Burstein, Skaidrite K. Krisans, Marcel Gut, Bertram I. Cohen, Raphael Pfeffer, Elliot R. Siegel, Lawrence M. Gartner and Kevin P. Morrissey. Their work appears in journals such as Journal of Biological Chemistry, Journal of Lipid Research, Pediatric Research, Developmental Medicine & Child Neurology and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.